Skip to main content
Center of Excellence in Urology & Men's Health (Pattaya, Chonburi, Rayong)
InnovationVideo Guide6 min read

IRE (NanoKnife) Focal Therapy for Early Prostate Cancer: Treating One Spot While Sparing Nerves

Learn how Irreversible Electroporation (IRE / NanoKnife) uses non-thermal electrical pulses to ablate localized low-to-intermediate-risk prostate cancer while preserving nearby nerves, blood vessels, and urinary continence.

IRE (NanoKnife) Focal Therapy for Early Prostate Cancer: Treating One Spot While Sparing Nerves
Specialist Video Guide · Dr. Niti Navanimitkul

IRE (NanoKnife) for Prostate Cancer: Treating Just One Spot | Patient Guide

@Dr.Niti-ProstateMensHealth

Video Chapters & Key Moments (Click to Jump)

Clinical Key Takeaways (At a Glance)

  • Non-Thermal Focal Ablation: Irreversible Electroporation (IRE / NanoKnife) destroys a single localized prostate tumor using short electrical pulses rather than heat or freezing.
  • Tissue-Sparing Mechanism: Preserves structural collagen around neurovascular bundles and the urethra, minimizing urinary incontinence and reducing erectile nerve injury compared with whole-gland surgery.
  • Strict Selection & Surveillance: Best suited for MRI-visible, biopsy-proven unifocal low-to-intermediate-risk disease, paired with mandatory PSA checks and 6–12 month MRI follow-up.

Historically, men diagnosed with localized prostate cancer faced an all-or-nothing choice between active surveillance and whole-gland radical treatments (surgery or radiotherapy), which can impact erections and bladder control. When cancer is confined to a single well-defined spot, Focal Therapy with IRE (NanoKnife) offers a targeted middle path—treating the tumor plus a safety margin while leaving healthy prostate tissue untouched.

How Non-Thermal Irreversible Electroporation Sparing Works

Under general anesthesia with complete muscle relaxation, Dr. Niti Navanimitkul places ultra-thin electrode needles through a sterile perineal template guided by real-time ultrasound and MRI fusion mapping—without a single scalpel incision. Microsecond high-voltage pulses open permanent nanoscale pores in cancer cell membranes, causing programmed cell death while sparing collagen frameworks in adjacent blood vessels, erectile nerves, and the urinary sphincter.

Who Suits IRE — And Who Does Not?

  • Potentially Suitable: Organ-confined prostate cancer, low-to-intermediate risk, one dominant index lesion on multiparametric MRI confirmed by targeted + systematic biopsy.
  • Not Recommended: Multifocal bilateral tumors, high-risk aggressive histology, or extraprostatic / metastatic spread.
  • Guideline Transparency: As Dr. Niti emphasizes, IRE is an encouraging modern focal modality with strong functional preservation, though long-term 10-to-15-year comparative data are still maturing alongside standard options.

Hospital Stay, Catheter Care & Mandatory Follow-Up

The procedure lasts 1 to 2 hours with a 1-night hospital stay. Because transient prostate swelling occurs after ablation, a soft urinary catheter remains in place for approximately 1 week. Urinary leakage is rare, though temporary urinary retention, mild hematuria, or changes in ejaculation/erections can occur in a subset of men. Post-treatment vigilancia—serial PSA blood testing, repeat multiparametric MRI at 6–12 months, and targeted re-biopsy if indicated—is essential. Schedule a focal therapy evaluation with Dr. Niti to review your MRI and pathology report.

Frequently Asked Clinical Questions

How does IRE (NanoKnife) differ from HIFU or cryotherapy for prostate cancer?
Unlike HIFU (high heat) or cryotherapy (extreme freezing), IRE uses ultra-short, high-voltage electrical pulses to create microscopic nanopores in cancer cell membranes without thermal tissue destruction. Because the extracellular collagen scaffold is preserved, nearby neurovascular bundles, blood vessels, and the urethra have a much higher chance of healing intact.
Who is an ideal candidate for IRE focal therapy?
IRE may suit men with localized low-to-intermediate-risk prostate cancer confined to one main MRI-visible lesion confirmed by targeted plus systematic prostate biopsy. It is generally unsuitable for multifocal, high-grade aggressive, or metastatic prostate cancer.
What is recovery like after IRE NanoKnife treatment?
IRE is performed under general anesthesia with muscle relaxant via fine needles through perineal skin (no surgical incision) in 1–2 hours. Most patients stay 1 night in hospital, keep a urinary catheter for about 7 days, and follow a strict surveillance protocol with serial PSA tests and repeat MRI at 6–12 months.

Ready to Start?